Senti Biosciences is trading at $0.33, up 6.45% in pre-market, with no fresh company announcement identified to explain the gain.
- Notable filings include a September 24 prospectus registering up to 25,555,024 shares for resale and a September 23 board resignation; neither has been directly linked to the rebound.
- The September 28 close was $0.31, down 5.86%; the supplied context also reports a 6.4% after-hours rise.
- The modestly mixed index backdrop does not establish a broader-market explanation.